Healthcare Pharmaceutical Biotech

CVS Health Marks 20 Years of Free Community Health Screening Program As New Survey Reveals Many U.S. Adults Still Face Barriers to Preventive Health Screenings

September 9, 2026 11:00 AM

New survey findings commissioned by CVS Health® (NYSE:CVS) reveal that many Americans face persistent barriers accessing preventive health screenings. Nearly one in four adults have delayed speaking with a health professional about health concerns because of barriers related to access, cost or availability, and one-third were unaware that community screening programs exist. "People aren't telling us that preventive health screenings don't...

Read more

BetterWay(TM) Blood Testing Shows How U.S. Logistics Can Help Expand Access to Healthcare at Made in America Summit

September 9, 2026 10:47 AM

BetterWay™ blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, will host an activation during the Made in America Summit on Thursday, September 10 from 12 pm - 5 pm. This activation is designed to spark conversation about the role logistics can play in addressing barriers to blood testing. Made in America is a two-day summit, hosted at STATION NWA in partnership with the...

Read more

ScienceSoft Expects 40% of Adults 55+ to Use AI-Powered Wearables for Health Alerts by 2030

September 9, 2026 10:35 AM

ScienceSoft has published a prediction article based on its proprietary research into the adoption of predictive AI-powered wearables among older adults. ScienceSoft forecasts that by 2030, around 40% of people aged 55 and older may use wearable devices powered by predictive AI to flag warning signs of serious health conditions. These could include both medical devices and consumer wearables, such as smartwatches. Rather than diagnosing...

Read more

Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market

September 9, 2026 9:30 AM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that it has received its first orders for its veterinary antimicrobial line, which will be marketed under the brand name C-ScrubVet. C-ScrubVet Wash 4% CHDG is a veterinary antimicrobial cleanser containing 4% chlorhexidine digluconate, effective against bacteria, fungi and enveloped viruses. It is...

Read more

Global Study: Nursing Shortages Require Workforce Policy Solutions, Not Recruitment Campaigns Alone

September 9, 2026 9:01 AM

The global nursing shortage cannot be solved simply by encouraging more people to enter the profession, according to a new evidence brief from the Global Nursing Workforce Centre (GNWC), a joint initiative of the International Council of Nurses (ICN) and TruMerit®. Drawing on research from 42 countries, the brief, The Attractiveness of Nursing for Prospective and Current Nursing Students, finds that the factors influencing people to choose...

Read more

WoundZoom Named 2026's Leading AI-Powered Wound Management Platform by Healthcare Tech Outlook

September 9, 2026 9:00 AM

WoundZoom, a leader in AI-powered wound care technology, has been recognized by Healthcare Tech Outlook as the AI Powered Wound Management Solutions Company of the Year 2026, acknowledging the company's impact on helping healthcare organizations improve wound assessment accuracy, reduce documentation burden, enable earlier clinical intervention and increase financial performance. The recognition comes at a time when healthcare providers are...

Read more

Alpha Genesis Launches AGI Ventures with an Initial $50 Million Commitment to Emerging Biotechnology Companies

September 9, 2026 9:00 AM

Alpha Genesis, Inc., a full-service preclinical contract research organization and the largest nonhuman primate research center in the United States, today announced the launch of AGI Ventures, a new strategic investment and venture-development division focused on emerging biotechnology companies. AGI Ventures launches with an initial $50 million commitment to support selected companies through a combination of research services and strategic...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Moves StrainScan Pro Forward as Initial Agricultural Demos Validate Platform Capabilities

September 9, 2026 8:57 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that its first StrainScan Pro demonstration sessions with agricultural operators generating high-value feedback that is now being used to expand and strengthen the platform. The update follows the Company's announcement that it was preparing custom demonstrations for enterprise agricultural clients. Those sessions are underway, and early operator response has been constructive and...

Read more

Bridging the Gap: How a Healthcare Caravan Is Strengthening Rural Care in Romania

September 9, 2026 8:35 AM

On a crisp November morning in Entregalde, a small village in Alba County, 63-year-old Oana wrapped her woolen scarf tightly as she walked toward the community center. Her fatigue and dizziness had become part of daily life-symptoms she had learned to ignore. But seeing a specialist at the hospital would normally mean hours of travel she could not manage. That day, a medical caravan had arrived in her village. Inside, cardiologists,...

Read more

Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program

September 9, 2026 8:30 AM

Aspire-Lakewood Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced the Board authorized a $10 million common stock repurchase program (the "Stock Repurchase Program"). This expanded share repurchase program is effective September 9, 2026. The expanded authorization reflects the Company's continued confidence in its long-term strategy as a holding company and strong free cash flow generation. Additionally, with common...

Read more

MDelite Introduces Eleo IPL on the iProElite Platform, Advancing Energy Delivery with Non-Contact Cooling

September 9, 2026 8:00 AM

MDelite, a medical technology company serving vision and aesthetic practices, announced the introduction of Eleo IPL on the MDelite iProElite platform. Eleo IPL is an intense pulsed light technology engineered to deliver energy uniformly, intentionally and predictably. The technology combines non-contact cooling, ultra-short pulses and a BK7 optical tip to support consistent energy delivery across the treatment area. Unlike water-cooled IPL...

Read more

National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort

September 9, 2026 7:29 AM

Organizations Across Sectors Unite Through the Winn Awards to Advance Better Science For All Previously published by the Robert A. Winn Excellence in Clinical Trials Award Program A growing coalition of pharmaceutical companies, nonprofit organizations, academic institutions, and clinical research leaders came together through the Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards) to train a new generation of physicians to...

Read more

Dr. Angela Fisher Selected to Deliver Oral Remarks at FDA Public Hearing on the Future Therapeutic Use of Psychedelic Drugs

September 9, 2026 7:00 AM

Dr. Angela Fisher, clinical psychologist, founder of Bionic Bloom and the Neurodivergent Empowerment Institute, and creator of Empowerment-Based Integrated Treatment (EBiT), has been selected to deliver in-person oral public comments at the U.S. Food and Drug Administration's "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs" Public Hearing on September 14, 2026, at the FDA's White Oak Campus in Silver Spring, Maryland....

Read more

Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica’s Marketing Engine: How Demand Becomes Revenue

September 9, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series, scheduled for Friday, September 25, 2026, at 4:00 p.m. Eastern Time. The September program, titled "Inside Zomedica's Marketing Engine: How Demand Becomes Revenue,"...

Read more

The National Children's Cancer Society (NCCS) Welcomes Clay Kniepmann to the Board of Directors

September 8, 2026 7:15 PM

The National Children's Cancer Society (NCCS) is proud to announce the addition of Clay Kniepmann to its Board of Directors. A longtime supporter of the organization and its mission, Kniepmann brings a passion for service, community leadership, and a commitment to helping families facing childhood cancer. Kniepmann's connection to the NCCS is deeply personal. Having experienced the impact of cancer within his own family, he was drawn to the...

Read more

Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress

September 8, 2026 6:25 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that the design, rationale and baseline data from its MEND-PNPO Phase 3 study (ClinicalTrials.gov NCT04706013) are being presented at the 16th European Epilepsy Congress (EEC), taking place September...

Read more

CV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory Framework

September 8, 2026 5:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today welcomed the enactment of federal legislation that delays implementation of significant changes to the federal definition of hemp and provides additional time for Congress and the Administration to develop a comprehensive...

Read more

Protagonist Therapeutics Announces $300 Million Share Repurchase Program

September 8, 2026 4:05 PM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $300 million of its outstanding common stock. The Company intends to fund the share repurchases from its cash, cash equivalents, and marketable securities, and from royalties and other payments received under the Company's collaboration arrangements with Takeda related to...

Read more

Appeals Court to Rule Soon on Marijuana Rescheduling as Billions in Cannabis Tax Benefits Hang in the Balance

September 8, 2026 3:33 PM

MMJ International Holdings, Inc. ("MMJ") today warned that a pending federal appeals court decision could disrupt billions of dollars in anticipated tax benefits and expose the central contradiction in the government's marijuana policy: State licensed marijuana products may receive Schedule III treatment even though the individual products have not been approved by the U.S. Food and Drug Administration or validated through product specific...

Read more

Who is the Best Cosmetic Surgeon in Washington State?

September 8, 2026 12:00 PM

For patients actively looking for the best cosmetic surgeon in Washington, Dr. Javad Sajan at Allure Esthetic has gained recognition across multiple media outlets for his work in cosmetic and gender-affirming surgery. Performing thousands of procedures for patients from Washington and around the world, he has been featured as Seattle's Best Plastic Surgeon by Seattle Mag and Seattle Met magazine. A triple board certified cosmetic surgeon with...

Read more